Additionally, we found that breast cancer cells that overexpress MEG8 have decreased the expression levels of some stem cell markers such as BMI1, SOX9 and KLF4 (Fig. 7G) and in some cases also NANOG or SOX2, but not OCT4 (Figure Supplementary S4A). This evidence concerns the gene MEG8 and breast cancer.